These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8235707)

  • 1. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
    Hehlmann R; Ansari H; Hasford J; Heimpel H
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives with interferon alpha. The German CML study group experience.
    Hehlmann R; Ansari H; Adelberger V; Heinze B; Hossfeld K; Hochhaus A; Heimpel H
    Bone Marrow Transplant; 1994; 14 Suppl 3():S14-20. PubMed ID: 7697004
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
    Hehlmann R; Heimpel H; Griesshammer M; Kolb HJ; Heinze B; Hossfeld DK; Wickramanayake PD; Essers U; Thiele J; Georgii A
    Leukemia; 1992; 6 Suppl 3():110S-114S. PubMed ID: 1602805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
    Hehlmann R; Kister P; Willer A; Simon M; Schenk M; Seifarth W; Papakonstantinou G; Saussele S; Kolb HJ; Ansari H
    Leukemia; 1994 Apr; 8 Suppl 1():S127-32. PubMed ID: 8152279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment choices in chronic myelogenous leukemia.
    Ready N; Freeman NJ; Carvalho A
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):95-8, 101. PubMed ID: 1522171
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to the treatment of chronic myeloid leukemia.
    Savage DG; Goldman JM
    Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
    Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Hochhaus A; Heinze B
    Blood; 1994 Dec; 84(12):4064-77. PubMed ID: 7994025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
    Hehlmann R; Heimpel H; Kolb HJ; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser WP; Essers U; Falge C
    Leuk Lymphoma; 1993; 11 Suppl 1():159-68. PubMed ID: 8251890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The analysis of failures in the treatment of children with chronic myelocytic leukemia in the studies of Polish pediatric leukemia/ lymphoma group].
    Chybicka A; Bogusławska-Jaworska J; Kałwak K; Turkiewicz D; Armata J; Balcerska A; Cwiklińska M; Hicke-Roberts A; Kaczmarek-Kanold M; Kołecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Wiśniewska-Slusarz H; Wysocki M; Wachowiak J
    Wiad Lek; 1998; 51 Suppl 4():33-9. PubMed ID: 10731941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic myeloid leukemia. State of the art, May 1993].
    Hehlmann R
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
    Petukhov VI; Strozha IL; Bondare DK
    Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
    [No Abstract]   [Full Text] [Related]  

  • 14. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M; Hehlmann R; Heimpel H
    Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of chronic myelogenous leukemia].
    Shibata A
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1318-30. PubMed ID: 8245626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interferon-alpha in the treatment of patients with chronic myeloid leukemia].
    Faber E; Jarosová M; Divoký V; Luhový M; Komenda S; Sulovská I; Hubácek J; Slezák P; Papajik T; Raida L; Heczko M; Indrák K
    Vnitr Lek; 1997 Jan; 43(1):13-7. PubMed ID: 9221559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic myeloid leukemia].
    Hehlmann R
    Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
    J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.